AbbVie (ABBV)
NYSE:ABBV
Holding ABBV?
Track your performance easily

AbbVie (ABBV) Technical Analysis

21,156 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is 1.49, suggesting AbbVie is a Buy.
AbbVie’s (ABBV) 20-Day exponential moving average is 194.15, while AbbVie’s (ABBV) share price is $193.39, making it a Sell.
AbbVie’s (ABBV) 50-Day exponential moving average is 188.24, while AbbVie’s (ABBV) share price is $193.39, making it a Buy.

AbbVie (ABBV) Pivot Points

Sep 19, 2024, 12:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
187.23
189.53
191.49
193.78
195.74
198.04
200.00
Fibonacci
189.53
191.15
192.16
193.78
195.41
196.41
198.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Sep 19, 2024, 12:13 PM
Period
Simple
Exponential
MA5
194.07Sell
194.06Sell
MA10
194.70Sell
194.61Sell
MA20
195.62Sell
194.15Sell
MA50
187.76Buy
188.24Buy
MA100
175.43Buy
180.26Buy
MA200
169.81Buy
170.11Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 194.61, while AbbVie’s (ABBV) share price is $193.39, making it a Sell.
AbbVie’s (ABBV) 100-Day exponential moving average is 180.26, while AbbVie’s (ABBV) share price is $193.39, making it a Buy.
AbbVie’s (ABBV) stock price is $193.39 and AbbVie’s (ABBV) 50-day simple moving average is 187.76, creating a Buy signal.
AbbVie’s (ABBV) stock price is $193.39 and AbbVie’s (ABBV) 100-day simple moving average is 175.43, creating a Buy signal.
AbbVie’s (ABBV) stock price is $193.39 and AbbVie’s (ABBV) 200-day simple moving average is 169.81, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

Sep 19, 2024, 12:13 PM
Name
Value
Implied Action
RSI (14)
49.85
Neutral
STOCH (9,6)
32.92
Neutral
STOCHRSI (14)
31.91
Neutral
MACD (12,26)
1.49
Buy
ADX (14)
35.90
Neutral
Williams %R
-80.76
Buy
CCI (14)
-112.60
Buy
ATR (14)
3.58
-
Ultimate Oscillator
56.92
Neutral
ROC
-1.26
Sell
AbbVie’s (ABBV) Relative Strength Index (RSI) is 49.85, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 35.90, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is -112.60, creating a Buy signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is -1.26, creating a Sell signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Hold.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 49.85, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is 1.49, which suggests ABBV is a Buy.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 194.07, which suggests ABBV is a Sell.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 195.62, which suggests ABBV is a Sell.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 187.76, which suggests ABBV is a Buy.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 169.81, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -80.76, which suggests ABBV is a Buy.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is -112.60, which suggests ABBV is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis